Literature DB >> 20724690

Can medicaid reimbursement help give female condoms a second chance in the United States?

Susan S Witte1, Kyle Stefano, Courtney Hawkins.   

Abstract

The female condom is the only other barrier contraception method besides the male condom, and it is the only "woman-initiated" device for prevention of sexually transmitted infections. Although studies demonstrate high acceptability and effectiveness for this device, overall use in the United States remains low. The female condom has been available through Medicaid in many states since 1994. We provide the first published summary of data on Medicaid reimbursement for the female condom. Our findings demonstrate low rates of claims for female condoms but high rates of reimbursement. In light of the 2009 approval of a new, cheaper female condom and the recent passage of comprehensive health care reform, we call for research examining how health care providers can best promote consumer use of Medicaid reimbursement to obtain this important infection-prevention device.

Entities:  

Mesh:

Year:  2010        PMID: 20724690      PMCID: PMC2936988          DOI: 10.2105/AJPH.2009.179598

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  11 in total

1.  The acceptability of the female condom: perspectives of family planning providers in New York City, South Africa, and Nigeria.

Authors:  J E Mantell; S Hoffman; E Weiss; L Adeokun; G Delano; T Jagha; T M Exner; Z A Stein; Q A Karim; E Scheepers; K Atkins; E Weiss
Journal:  J Urban Health       Date:  2001-12       Impact factor: 3.671

Review 2.  Female-initiated barrier methods for the prevention of STI/HIV: where are we now? Where should we go?

Authors:  M Latka
Journal:  J Urban Health       Date:  2001-12       Impact factor: 3.671

3.  HIV in the United States at the turn of the century: an epidemic in transition.

Authors:  J M Karon; P L Fleming; R W Steketee; K M De Cock
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

Review 4.  A review of female-condom effectiveness: patterns of use and impact on protected sex acts and STI incidence.

Authors:  Gowri Vijayakumar; Zonke Mabude; Jenni Smit; Mags Beksinska; Mark Lurie
Journal:  Int J STD AIDS       Date:  2006-10       Impact factor: 1.359

5.  The female condom: still an underused prevention tool.

Authors: 
Journal:  Lancet Infect Dis       Date:  2008-06       Impact factor: 25.071

6.  Female condom promotion needed.

Authors:  Susie Hoffman; Jennifer A Smit; Jessica Adams-Skinner; Theresa Exner; Joanne Mantell; Zena Stein
Journal:  Lancet Infect Dis       Date:  2008-06       Impact factor: 25.071

7.  Male-condom and female-condom use among women after counseling in a risk-reduction hierarchy for STD prevention.

Authors:  M Latka; E Gollub; P French; Z Stein
Journal:  Sex Transm Dis       Date:  2000-09       Impact factor: 2.830

8.  Cost-effectiveness of the female condom in preventing HIV and STDs in commercial sex workers in rural South Africa.

Authors:  E Marseille; J G Kahn; K Billinghurst; J Saba
Journal:  Soc Sci Med       Date:  2001-01       Impact factor: 4.634

9.  Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994-2003.

Authors:  Athena P Kourtis; Pooja Bansil; Melissa McPheeters; Susan F Meikle; Samuel F Posner; Denise J Jamieson
Journal:  AIDS       Date:  2006-09-11       Impact factor: 4.177

10.  Adding the female condom to the public health agenda on prevention of HIV and other sexually transmitted infections among men and women during anal intercourse.

Authors:  Elizabeth A Kelvin; Raymond A Smith; Joanne E Mantell; Zena A Stein
Journal:  Am J Public Health       Date:  2009-04-16       Impact factor: 9.308

View more
  2 in total

1.  Medicaid Reimbursement for the Female Condom.

Authors:  Susan S Witte; Colleen MacPhee; Natalie Ginsburg; Neha Deshmukh
Journal:  Am J Public Health       Date:  2017-08-17       Impact factor: 9.308

2.  Initial and sustained female condom use among low-income urban U.S. women.

Authors:  Margaret R Weeks; Emil Coman; Helena Hilario; Jianghong Li; Maryann Abbott
Journal:  J Womens Health (Larchmt)       Date:  2012-12-31       Impact factor: 2.681

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.